Shih–Jer Hsu

1.3k total citations
34 papers, 875 citations indexed

About

Shih–Jer Hsu is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Shih–Jer Hsu has authored 34 papers receiving a total of 875 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hepatology, 24 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Shih–Jer Hsu's work include Liver Disease Diagnosis and Treatment (21 papers), Hepatitis C virus research (18 papers) and Hepatitis B Virus Studies (15 papers). Shih–Jer Hsu is often cited by papers focused on Liver Disease Diagnosis and Treatment (21 papers), Hepatitis C virus research (18 papers) and Hepatitis B Virus Studies (15 papers). Shih–Jer Hsu collaborates with scholars based in Taiwan and United States. Shih–Jer Hsu's co-authors include Jia‐Horng Kao, Chen‐Hua Liu, Chun‐Jen Liu, Pei‐Jer Chen, Ding‐Shinn Chen, Tai‐Chung Tseng, Ching‐Sheng Hsu, Tung‐Hung Su, Cheng‐Chao Liang and Ming‐Shiang Wu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and PLoS ONE.

In The Last Decade

Shih–Jer Hsu

33 papers receiving 852 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shih–Jer Hsu Taiwan	15	474	466	329	135	132	34	875
H Thompson United Kingdom	11	293 0.6×	176 0.4×	454 1.4×	75 0.6×	235 1.8×	22	847
S. Pretolani Italy	14	119 0.3×	172 0.4×	491 1.5×	212 1.6×	159 1.2×	25	725
Fibo J.W. ten Kate Netherlands	16	187 0.4×	181 0.4×	330 1.0×	142 1.1×	142 1.1×	24	665
Órla Crosbie Ireland	13	331 0.7×	355 0.8×	175 0.5×	79 0.6×	26 0.2×	39	754
Yukihiko Tokunaga Japan	19	731 1.5×	170 0.4×	1.1k 3.2×	46 0.3×	172 1.3×	64	1.3k
Frank Zerbib France	13	76 0.2×	243 0.5×	490 1.5×	69 0.5×	102 0.8×	31	787
Sanjay Govil India	15	162 0.3×	217 0.5×	502 1.5×	55 0.4×	334 2.5×	39	811
Airi Jussila Finland	14	84 0.2×	499 1.1×	448 1.4×	146 1.1×	168 1.3×	26	888
Shee‐Chan Lin Taiwan	14	147 0.3×	154 0.3×	290 0.9×	124 0.9×	186 1.4×	39	575
S. Recchia Italy	13	500 1.1×	546 1.2×	283 0.9×	68 0.5×	303 2.3×	36	998

Countries citing papers authored by Shih–Jer Hsu

Since Specialization

Citations

This map shows the geographic impact of Shih–Jer Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shih–Jer Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shih–Jer Hsu more than expected).

Fields of papers citing papers by Shih–Jer Hsu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shih–Jer Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shih–Jer Hsu. The network helps show where Shih–Jer Hsu may publish in the future.

Co-authorship network of co-authors of Shih–Jer Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Shih–Jer Hsu. A scholar is included among the top collaborators of Shih–Jer Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shih–Jer Hsu. Shih–Jer Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Ming‐Shun, Wei‐Yu Kao, Shih–Jer Hsu, et al.. (2025). Consensus Guideline of Ablation for Metastatic Liver Tumors by Taiwan Academy of Tumor Ablation. Liver Cancer. 15(1). 149–164.

Su, Tung‐Hung, Sih‐Han Liao, Tai‐Chung Tseng, et al.. (2024). Tenofovir versus entecavir on recurrence and mortality of hepatitis B virus-related hepatocellular carcinoma after curative therapy. Journal of the Formosan Medical Association. 123(8). 891–898. 3 indexed citations

Huang, Shang‐Chin, Tung‐Hung Su, Tai‐Chung Tseng, et al.. (2024). All-cause and cause-specific mortality in patients with chronic hepatitis B and concurrent steatotic liver disease. Journal of Hepatology. 83(1). 43–51. 9 indexed citations

Su, Tung‐Hung, Shang‐Chin Huang, Tai‐Chung Tseng, et al.. (2023). Optimizing Survival Benefit by Surgical Resection by the Seven-Eleven Criteria in Barcelona Clinic Liver Cancer Stage A/B Hepatocellular Carcinoma beyond the Milan Criteria. Liver Cancer. 12(6). 539–549. 1 indexed citations

Su, Tung‐Hung, Shang‐Chin Huang, Chi‐Ling Chen, et al.. (2023). Pre-operative gamma-glutamyl transferase levels predict outcomes in hepatitis B-related hepatocellular carcinoma after curative resection. Journal of the Formosan Medical Association. 122(10). 1008–1017. 3 indexed citations

Huang, Shang‐Chin, Tung‐Hung Su, Tai‐Chung Tseng, et al.. (2023). Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B. Hepatology International. 17(5). 1139–1149. 25 indexed citations

Ho, Ming‐Chih, Jia‐Horng Kao, Cheng‐Maw Ho, et al.. (2023). Effects of transjugular intrahepatic portosystemic shunt on abdominal muscle mass in patients with decompensated cirrhosis. Journal of the Formosan Medical Association. 122(8). 747–756. 3 indexed citations

Su, Tung‐Hung, Chieh‐Chang Chen, Wei‐Kai Wu, et al.. (2023). Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease. Gut Pathogens. 15(1). 24–24. 10 indexed citations

Huang, Shang‐Chin, Tung‐Hung Su, Tai‐Chung Tseng, et al.. (2023). Metabolic Dysfunction-Associated Steatotic Liver Disease Facilitates Hepatitis B Surface Antigen Seroclearance and Seroconversion. Clinical Gastroenterology and Hepatology. 22(3). 581–590.e6. 28 indexed citations

10.

Hong, Chun‐Ming, Chun‐Jen Liu, Shiou‐Hwei Yeh, et al.. (2021). Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan. Viruses. 13(11). 2294–2294. 1 indexed citations

11.

Su, Tung‐Hung, Shih–Jer Hsu, & Jia‐Horng Kao. (2021). Paradigm shift in the treatment options of hepatocellular carcinoma. Liver International. 42(9). 2067–2079. 28 indexed citations

12.

Hsu, Shih–Jer, Yu‐Jen Fang, Tsung‐Hua Yang, et al.. (2019). Real-world effectiveness and safety of glecaprevir/pibrentasvir in Asian patients with chronic hepatitis C. Journal of the Formosan Medical Association. 118(8). 1187–1192. 16 indexed citations

13.

Hsu, Ching‐Sheng, Shih–Jer Hsu, Wei‐Liang Liu, Ding‐Shinn Chen, & Jia‐Horng Kao. (2016). Association of SCARB1 Gene Polymorphisms with Virological Response in Chronic Hepatitis C Patients Receiving Pegylated Interferon plus Ribavirin Therapy. Scientific Reports. 6(1). 32303–32303. 9 indexed citations

14.

Hsu, Ching‐Sheng, Shih–Jer Hsu, Hans Hsienhong Lin, et al.. (2014). A pilot study of add-on oral hypoglycemic agents in treatment-naïve genotype-1 chronic hepatitis C patients receiving peginterferon alfa-2b plus ribavirin. Journal of the Formosan Medical Association. 113(10). 716–721. 10 indexed citations

15.

Hsu, Shih–Jer, Ming‐Lun Han, Ping‐Huei Tseng, et al.. (2012). Randomised clinical trial: high‐dose vs. standard‐dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers. Alimentary Pharmacology & Therapeutics. 35(8). 894–903. 24 indexed citations

16.

Hsu, Ching‐Sheng, Shih–Jer Hsu, Hung-Chia Chen, et al.. (2012). Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients. Hepatology International. 7(1). 171–179. 5 indexed citations

17.

Liou, Jyh‐Ming, Chieh‐Chang Chen, Chung‐Yu Chang, et al.. (2012). Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial. Journal of Antimicrobial Chemotherapy. 68(2). 450–456. 68 indexed citations

18.

Liu, Chen‐Hua, Cheng‐Chao Liang, Chun‐Jen Liu, et al.. (2010). The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C. Kidney International. 78(1). 103–109. 29 indexed citations

19.

Liu, Chen‐Hua, Chun‐Jen Liu, Chih‐Lin Lin, et al.. (2008). Pegylated Interferon‐α‐2a plus Ribavirin for Treatment‐Naive Asian Patients with Hepatitis C Virus Genotype 1 Infection: A Multicenter, Randomized Controlled Trial. Clinical Infectious Diseases. 47(10). 1260–1269. 152 indexed citations

20.

Liu, Chen‐Hua, Shih–Jer Hsu, Juey‐Jen Hwang, et al.. (2007). Noninvasive Diagnosis of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Splenic Doppler Impedance Index. Clinical Gastroenterology and Hepatology. 5(10). 1199–1206.e1. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact